Latest filing published 29 Mar 2023 for Rani Therapeutics Holdings, Inc..
Insider track record
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Mir Hashim: trading record in brief
This profile gathers the share dealings of Mir Hashim in Rani Therapeutics Holdings, Inc., where the filings describe the role as senior executive. Over a trading history stretching from 9 September 2021 to 27 March 2023, the count stands at 5 filings.
Not one of the filings records a straightforward purchase or sale on the market. Because grants and exercises are largely decided by remuneration plans, they are not counted as purchases here.
Most recently, on 29 March 2023, the filings show a share grant in Rani Therapeutics Holdings, Inc. The median gap between a trade and its publication by SEC (Form 4) is 2 days. For comparison, the SEC allows two business days to file a Form 4. Source: insider filings from SEC (Form 4). Past trades are no guide to future returns.
Companies and markets linked to Mir Hashim
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 139,000 shares0Class A Common StockSEC:0001415889-23-005598:0
- 4,201 shares@ US$5.9510.4% of flowClass A Common StockSEC:0000899243-23-009584:0
- 20,334 shares@ US$9.8989.6% of flowClass A Common StockSEC:0001209191-22-049800:0
- 41,200 shares0Class A Common StockSEC:0001209191-22-021018:0
- 117,600 shares0Class A Common StockSEC:0001209191-21-055764:0
5 of 5 declarations